Providing COVID-19 Therapeutics and Clinical Guidance in Skilled Nursing Facilities

Christy Zelinski,Sylwia Jasniuk,Linda Li,Dheeraj Mahajan,Kelly Walblay,Leirah Jordan,Do Young Kim,Stephanie Black
DOI: https://doi.org/10.1016/j.jamda.2024.03.104
IF: 7.802
2024-05-02
Journal of the American Medical Directors Association
Abstract:Residents in skilled nursing facilities (SNFs) are at high risk for hospitalization and death from COVID-19 (1,2). Outpatient COVID-19 therapeutics reduce severe illness, and they became more available locally as of April 25, 2022 (3,4). However, evolving guidance and medication administration logistics created barriers to timely use of therapeutics for SNF residents in a large metropolitan city. October 31, 2022, 8.1% reported COVID-19 cases among area SNF residents (n=1,957) were treated with
geriatrics & gerontology,gerontology
What problem does this paper attempt to address?